SVF Endurance (Cayman) Ltd is 10% Owner at Vir Biotechnology, Inc. (VIR). They have made 18 open-market trades across 3 companies since 2020, most recently 2025-12-01.
CIK 0001782338
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 18 sales. Too few scored purchases to measure a record yet.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 67% | 67% | 83% |
| Avg Move | -1.6% | -7.8% | -20.6% |
| Scored | 18 | 18 | 18 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VIR | SELL · 10b5-1 | 2025-12-01 | 2025-12-03 | $5.98 | $2.3M | +8.9% | -3.7% | +44.4% |
| VIR | SELL · 10b5-1 | 2025-11-24 | 2025-11-26 | $6.27 | $5.8M | +3.9% | -6.4% | +48.0% |
| VIR | SELL · 10b5-1 | 2025-10-28 | 2025-10-30 | $6.50 | $319K | -2.7% | +3.4% | +29.0% |
| VIR | SELL · 10b5-1 | 2025-10-20 | 2025-10-22 | $6.25 | $2.7M | -8.0% | -6.7% | -1.5% |
| VIR | SELL · 10b5-1 | 2025-10-15 | 2025-10-17 | $6.08 | $359K | -0.8% | -7.9% | +4.0% |
| VIR | SELL · 10b5-1 | 2025-10-03 | 2025-10-07 | $5.58 | $5.8M | +1.6% | -10.0% | +1.8% |
| COMP | SELL | 2025-03-24 | 2025-03-26 | $9.15 | $91.5M | -13.0% | -20.8% | -30.8% |
| VIR | SELL | 2023-06-20 | 2023-06-22 | $25.18 | $499K | -1.7% | -43.4% | -62.2% |
| VIR | SELL | 2023-06-15 | 2023-06-20 | $25.56 | $9.4M | -0.4% | -48.4% | -60.9% |
| VIR | SELL | 2023-06-13 | 2023-06-15 | $26.75 | $8.8M | -4.8% | -11.9% | -61.7% |
| VIR | SELL | 2023-05-19 | 2023-05-23 | $25.55 | $9.4M | -0.2% | -6.8% | -52.5% |
| VIR | SELL | 2023-05-01 | 2023-05-03 | $25.30 | $156K | +1.5% | +8.0% | -43.6% |
| VIR | SELL | 2023-04-20 | 2023-04-24 | $25.76 | $16.1M | +0.7% | +3.1% | -44.6% |
| VIR | SELL | 2023-04-18 | 2023-04-20 | $25.12 | $4.2M | -1.0% | +3.5% | -7.4% |
| VIR | SELL | 2023-02-21 | 2023-02-23 | $28.42 | $4.1M | -5.8% | -4.9% | +7.9% |
| VIR | SELL | 2023-02-09 | 2023-02-13 | $26.28 | $12.3M | -11.5% | -9.5% | -1.3% |
| VIR | SELL | 2023-02-07 | 2023-02-09 | $28.51 | $8.3M | +3.1% | -14.0% | -6.8% |
| VIR | SELL | 2023-02-01 | 2023-02-03 | $29.41 | $8.7M | -10.6% | -22.8% | -14.7% |
| VIR | SELL | 2023-01-10 | 2023-01-12 | $26.32 | $7.9M | +16.6% | -1.0% | -10.4% |
| VIR | SELL | 2022-12-29 | 2023-01-03 | $25.55 | $2.3M | +6.0% | +19.4% | -7.1% |
| VIR | SELL | 2022-12-27 | 2022-12-29 | $25.59 | $351K | +5.4% | +17.2% | -8.5% |
| VIR | SELL | 2022-11-28 | 2022-11-30 | $27.41 | $6.0M | -7.7% | -8.4% | -17.5% |
| VIR | SELL | 2022-11-07 | 2022-11-09 | $27.26 | $9.9M | -0.4% | -5.2% | +9.8% |
| GH | SELL | 2020-10-09 | 2020-10-13 | $101.08 | $707.6M | -4.7% | +5.6% | +40.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.